Related Experiment Video
Updated: Aug 15, 2026

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
Published on: January 3, 2017
Physicians' perspective regarding direct to consumer marketing of nutraceuticals products
Kamran Zaman1, Kiran Asim2, Nusrat Shah3
1Kamran Ali Zaman, Pharm-D, MBA. Marketing Manager and CRA, PharmEvo (Pvt.) Ltd, Karachi, Pakistan.
Objectives:
Recently pharmaceutical marketers have expanded their audience by directly to the consumers advertising (DTCA) which is almost always limited to non-prescription drugs. DTCA has substantial effects on patient behavior and physician prescription. The aim of this study was to assess the perspectives of physicians regarding the rapidly proliferating trend of direct to consumer marketing of nutraceutical drugs (ND).
Methods:
It was a cross-sectional study from June 2016 to December 2016 which included 325 physicians from various cities of Pakistan who completed a structured questionnaire after providing informed consent. Questions were asked to assess physicians' perception of the increasing trend of Direct to Consumer advertisement of nutraceuticals and its influence on their practice. The data was analyzed using SPSS (SPSS Inc., Chicago, Illinois, USA).
Results:
There were 182 (56%) male and 143 (44%) female physicians in the study. Most of them were general practitioners (48%), spent an average weekly time of 1-2 hours gaining medical knowledge (56%), and most of them (52%) utilized internet as their source. Most physicians (88%, n=286) experienced knowledgeable patients who inquired about their diseases and treatment plans. Most of the physicians believed that e-detailing (72%, n=234) and DTCA (68%, n=221) of nutraceuticals helps practitioners in shaping a more effective treatment plan. Almost (62%, n=201) physicians prescribed medications their patients requested them to.
Conclusion:
Physician perception of DTCA and e-detailing of nutraceuticals seems to be promising. However, physicians must be more prepared to deal with knowledgeable patients and put in maximum efforts to counsel them in such a manner that the prescription doesn't contain "request specific" drugs but only the ones that are most beneficial for the patients.
Related Concept Videos
Drug Regulation
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

